Gynecologic malignancies, consisting of endometrial, cervical, ovarian, vulvar, and vaginal
cancers, pose significant diagnostic and management challenges due to their complex …

Gynecologic cancers are a worldwide problem among women. Recently, molecular targeted
therapy opened up an avenue for cancer diagnosis and treatment. Long non-coding RNAs …

Gynecological cancers pose an important public health issue, with a high incidence among
women of all ages. Gynecological cancers such as malignant germ-cell tumors, sex-cord …

Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility.
The identification of new predictive markers and therapeutic targets for the treatment of …

Gynecological cancers (GCs) are currently among the major threats to female health.
Moreover, there are different histologic subtypes of these cancers, which are defined as …

Rare ovarian cancers are ovarian cancers with an annual incidence of less than 6 cases per
100,000 women. They generally have a poor prognosis due to being delayed diagnosis and …

Gynaecological cancers (GCs) comprise a group of cancers that originate in the female
reproductive organs. Each GC is unique, with different signs and symptoms, risk factors and …

Despite the ongoing progress in detecting and treating cancer, there is still a need for
extensive research into the molecular mechanisms involved in the emergence, progression …

The main types of gynecologic cancers (GCs) include ovarian, uterine (endometrial cancer
and uterine sarcoma), and cervical. In spite of often being grouped together, each GC has …

Simple Summary Ovarian cancers (OCs) are the most lethal form of gynecological tumors.
The commonest are high-grade serous OCs, while rare OCs originate from many different …